Get startedLog in
    Picture of Takeda Pharmaceutical logo

    4502 — Takeda Pharmaceutical News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeLarge CapMomentum Trap
    All News

    US FDA approves Takeda, Protagonist's drug for rare blood cancer

    Picture of Takeda Pharmaceutical logoTakeda Pharmaceutical
    28/08/2026 22:37
    US FDA approves Takeda, Protagonist's drug for rare blood cancer
    Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved a first-of-its-kind drug from Takeda Pharmaceutical 4502.T and Protagonist Therapeutics PTGX.O to treat a rare blood cancer, the health regulator said on Friday.

     (Reporting by Kamal Choudhury, Mariam Sunny and Christy Santhosh in Bengaluru; Editing by Vijay Kishore)
     ((Kamal.Choudhury@thomsonreuters.com;))

    Recent news on Takeda Pharmaceutical

    See all news